TB Mukt Bharat: JOSH campaign and India’s TB decline vs the world
Next story · 13 OctNLMC’s first end-to-end e-auction of RINL land: ₹366.33 crore on Day 1
A PIB backgrounder on 13 October 2026 says India’s yearly emerging TB cases fell 21% from 2015 to 2024, against a 12% global fall. Treatment coverage is 92% versus 78% worldwide. The same day a JOSH youth campaign began in 11 States and 55 districts to push screening, treatment and stigma reduction.
- TB incidence fall
- India 21%, world 12%
- Treatment coverage
- India 92%
- TB deaths
- Down 28%
- JOSH pilot
- 11 States, 55 districts
India’s TB elimination drive: what happened?
India still carries a large share of the world’s TB burden, but the pace of decline has beaten the global average. The new push is less about a new drug and more about finding missing patients and keeping them on treatment through the community.
- A PIB backgrounder on 13 October 2026 says India’s yearly emerging TB cases fell 21% between 2015 and 2024, against a global decline of 12% (WHO Global Tuberculosis Report 2025); treatment coverage is 92% versus 78% globally.
- The same day the Ministry launched a JOSH (Joint Squad for Health) social-media campaign on a pilot in 11 States and 55 districts, with MY BHARAT volunteers, NCC cadets and a Class-I officer in each team.
- Under the intensified TB Mukt Bharat Abhiyaan, screenings have crossed 28.1 crore, over 20 lakh people got TB Preventive Treatment, 5.7 lakh new Nikshay Mitras were added, and 46,118 Gram Panchayats have TB-free certification.
What is NTEP?
- In 2020 the Revised National Tuberculosis Control Program (RNTCP) was renamed the National TB Elimination Programme (NTEP), signalling a goal to eliminate TB before the global 2030 target.
- The National Strategic Plan to End TB in India 2020-25 (announced June 2020) rests on four pillars: Detect, Treat, Prevent, Build.
- It aligns with Sustainable Development Goal 3 on health and well-being.
What is Pradhan Mantri TB Mukt Bharat Abhiyaan?
- Launched on 9 September 2022 as a Jan Andolan under NTEP: extra support to patients, more community involvement, and use of CSR.
- A 100-day drive began on 7 December 2024 in 347 high-priority districts across 33 States and UTs; its methods are now scaled nationwide.
- Treatment success under the Abhiyan has risen to 90%, above the global average of 88%.
Nutrition and “TB Friends”
| Scheme or role | What it does |
|---|---|
| Nikshay Poshan Yojana (2018) | ₹1,000 a month to each notified TB patient; Rs.4,454.68 crore paid to 1.38 crore beneficiaries since April 2018 |
| Ni-kshay Mitra | A volunteer (person, NGO, firm or public figure) who gives food baskets, psychosocial support and vocational help |
| As of 12 Nov 2025 | 6,77,541 Mitras; over 45 lakh food baskets; over 2 lakh MY Bharat volunteers as Mitras |
What is the BPaLM regimen?
- BPaLM combines Bedaquiline, Pretomanid, Linezolid and Moxifloxacin for drug-resistant TB.
- It shortens treatment to about 6 months. More than 15,000 MDR/RR-TB patients have been started on it under the programme.
What new tools sit behind the screening surge?
| Tool | Scale or role |
|---|---|
| Rapid molecular testing | More than 9,800 facilities |
| Culture and drug-susceptibility labs | 107 (described as the world’s largest such network) |
| AI-enabled handheld chest X-rays | Over 500 in use; 1,500 being delivered to States and UTs; 34-fold rise in X-ray screening |
| TB Mukt Bharat App | AI chatbot “Khushi” for symptoms, progress and nearby centres |
| Ayushman Arogya Mandirs | 1,87,250 centres (as on 13 Oct 2026) for first-contact screening |
| Helpline | Ni-kshay Sampark TB and Hepatitis: 1800-11-6666 |
How is the JOSH campaign meant to work?
Youth teams for TB awareness
- Pilot in 11 States and 55 districts
- Each JOSH team: MY BHARAT volunteers + NCC cadets + Class-I officer
- Push screening, early detection, adherence, stigma reduction
- Posts and stories amplify the Jan Andolan
- Link people to free NTEP diagnosis and treatment
Why does India’s TB elimination drive matter?
| Angle | What to note |
|---|---|
| Public health | Faster fall in incidence than the world average; high treatment coverage. |
| Technology | Handheld X-rays, AI triage and a chatbot cut the wait for diagnosis. |
| Nutrition | Cash and food baskets attack the reason patients drop out of long treatment. |
| Community | Nikshay Mitras and JOSH turn TB control into a people’s campaign. |
| Federal | Ayushman Arogya Mandirs and State delivery of handheld X-rays carry the last mile. |
What are the challenges in India’s TB elimination drive?
- A 21% fall still leaves a large absolute burden; missing asymptomatic cases remain the hard part.
- Drug-resistant TB needs shorter regimens and tight follow-up; BPaLM coverage is still in the tens of thousands.
- Stigma keeps people from testing; a social-media campaign helps only if local health workers back it.
- Private-sector patients must still be notified and supported if national numbers are to stay honest.
What should be done next on India’s TB elimination drive?
- Expand JOSH beyond the 55-district pilot with measured screening gains.
- Keep scaling handheld X-rays and BPaLM with radiographer posts under NHM.
- Publish district-wise TB-free Gram Panchayat outcomes, not only counts.
- Hold the link between Nikshay Poshan transfers and treatment completion.
What can Prelims ask on India’s TB elimination drive?
- India TB incidence fall 21% vs world 12% (2015-2024); deaths down 28%.
- NTEP renamed from RNTCP in 2020; NSP 2020-25: Detect, Treat, Prevent, Build.
- PMTBMBA launched 9 September 2022.
- Nikshay Poshan: ₹1,000/month since 2018.
- BPaLM: 6-month drug-resistant regimen.
- JOSH: 11 States, 55 districts; helpline 1800-11-6666.
How to write about India’s TB elimination drive in Mains
Practice question (10 marks, 150 words): “Community participation can do for TB what technology alone cannot.” Examine with reference to TB Mukt Bharat and the JOSH campaign. (150 words)
- Intro: 21% vs 12% decline; still a high-burden country.
- State tools: NTEP, molecular labs, BPaLM, handheld X-rays.
- Community tools: Nikshay Mitra, Poshan, JOSH, Gram Panchayat certification.
- Gaps: asymptomatic cases, DR-TB, private sector, stigma.
- Conclusion: Jan Andolan plus diagnostics as the twin track.
How to use this in Mains
If asked: India's progress against TB is ahead of global trends, but challenges remain. Critically examine. (GS-II)
Quote: “A PIB backgrounder on 13 October 2026 says India’s yearly emerging TB cases fell 21% from 2015 to 2024, against a 12% global fall.”
Use it: The perfect opening data point; follow with missing cases and drug resistance as challenges.
Exam angle
Prelims: NTEP, BPaLM, Nikshay Poshan, JOSH, WHO report figures. · Mains GS-II: health programmes; SDG 3; community mobilisation.
Practice MCQs
Original practice questions (not PYQs).
With reference to tuberculosis control in India, consider the following statements:
1. Between 2015 and 2024, yearly emerging TB cases in India fell faster than the global average.
2. Nikshay Poshan Yojana provides ₹1,000 per month to each notified TB patient.
Which of the statements given above is/are correct?
Answer (c) & explanation
PIB backgrounder, 13 Oct 2026.
The BPaLM regimen, introduced for drug-resistant TB, shortens treatment to about
Answer (c) & explanation
PIB backgrounder, 13 Oct 2026.
Questions students ask about this
How fast is TB falling in India compared with the world?
Yearly emerging cases fell 21% in India between 2015 and 2024, against 12% globally (WHO Global TB Report 2025).
What is JOSH?
Joint Squad for Health: youth teams (MY BHARAT, NCC, a Class-I officer) piloted in 11 States and 55 districts from 13 October 2026 to push TB awareness and screening.
What is Nikshay Poshan Yojana?
A 2018 scheme that pays ₹1,000 a month to each notified TB patient for nutrition.
What is BPaLM?
A shorter drug-resistant TB regimen of Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, lasting about 6 months.
When was RNTCP renamed NTEP?
In 2020.
Keep studying
Go deeper
Official source: PIB: Towards a TB-Free India, 13 Oct 2026
facts from cited sources only; faculty review pending